Searching For A Legal Pathway For CBD Products

By Maggie Craig, Stefanie Fogel, John Packman and Jae Kim (September 19, 2019, 4:19 PM EDT) -- When the 2018 Farm Bill removed hemp from the definition of marijuana — and thus from the list of Schedule I drugs under the Controlled Substance Act, or CSA — it unlocked an industry ripe for expansion. Sales of products containing CBD are booming — indeed, analysts predict that CBD sales could become a $15-$20 billion industry by 2025.[1]...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!